The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IASLC TTLC 2024 | Advances in radiotherapy for lung cancer
Puneeth Iyengar, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, highlights research focuses for the improvement of radiotherapy for lung cancer. Improved imaging techniques, such as FDG PET scans, for precise therapy targeting may help focus radiotherapy on active regions of a tumor to minimize damage to normal tissue. This interview took place at 2024 Targeted Therapies of Lung Cancer Meeting (TTLC 2024) in Santa Monica, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
